8 completed. 6 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 6 |
| Phase 2 | 2 | Completed 2 |
Follow AZD8848: new trials by email Literature Review of AZD8848 trials Research Report on AZD8848
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses AZD8848 in Healthy Subjects AZD8848, Placebo to match AZD8848 - Safety,, Tolerability, | Phase 1 | Completed | AstraZeneca | 8 | 2014-01-01 | 2015-08-14 |
| AZD8848 Single Ascending Dose Study AZD8848, Placebo - Healthy | Phase 1 | Completed | AstraZeneca | 47 | 2012-05-01 | 2016-06-06 |
| A Study to Investigate the Impact of Dose and Dosing Frequency of AZD8848 on the Response on Biomarkers AZD8848, Placebo - Healthy Volunteers | Phase 1 | Completed | AstraZeneca | 55 | 2010-11-01 | 2015-08-14 |
| Efficacy Study in Allergic Rhinitis Patients After Intranasal Administration of AZD8848 AZD8848, Placebo, AZD8848 and placebo - Allergic Rhinitis | Phase 2 | Completed | AstraZeneca | 93 | 2010-09-01 | 2016-01-07 |
| Study to Investigate the Safety and Tolerability of AZD8848 in Butyrylcholinesterase Deficient Subjects AZD8848 - Butyrylcholinesterase Deficiency | Phase 1 | Completed | AstraZeneca | 22 | 2010-09-01 | 2015-08-14 |
| The Tolerability and Effects of AZD8848 in Allergic Asthma Subjects Challenged With Inhaled Allergen AZD8848, Placebo - Allergic Asthma | Phase 2 | Completed | AstraZeneca | 60 | 2009-10-01 | 2016-02-26 |
| Tolerability/PoP Study in Allergic Rhinitis After Intranasal Administration of AZD8848 AZD8848, Placebo - Allergic Rhinitis | Phase 1 | Completed | AstraZeneca | 103 | 2008-09-01 | 2015-08-14 |
| Tolerability/Safety of Intranasal AZD8848 in Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of Season AZD8848, Placebo - Healthy, Allergic Rhinitis | Phase 1 | Completed | AstraZeneca | 130 | 2008-01-01 | 2015-08-14 |
Rhinitis, Allergic (3) · Respiratory Aspiration (2) · Butyrylcholinesterase deficiency (1)
AstraZeneca (8)
Sweden (4) · United Kingdom (3) · Denmark (1)
Leif T Eriksson, MD, PhD (2) · Sam Lindgren, MD, PhD (2) · Ajay Aggarwal (1) · Aray Aggarwal (1) · Brian Leaker, MD (1) · James Ritter, BA,MA D Phil,BM BCh,MRCP,FRCP (1) · Jesper Sonne, MD (1) · Leif Eriksson, MD (1) · Leif T Eriksson (1) · Lennart Greiff, MD PhD (1) · Lennart Greiff, MD, PhD (1) · Tim Mant, BSc, MB BS, MRCP, FRCP, FFPM (1) · Wolfgang Kuhn, MD (1)